Anteris Technologies Ltd discontinued with upcoming capital raising announcement

The titles will remain suspended until Monday, August 2, 2021 or when an announcement is published on the market.

Anteris Technologies Ltd (ASX: AVR, OTC: AMEUF, FRA: DDF) has been granted a halt in trading by ASX with the announcement of a pending fundraising proposal.

The stop will remain in place until regular trading begins on Monday, August 2, or until an announcement is posted to the market, whichever occurs first.

Patent issued

The company recently obtained a patent for its invention “Sterilized Packaging System for Catheter” from the Commonwealth of Australia Patent Office.

Sterilization of surgical products used in vivo is essential, and having a specialized and proprietary sterilization system reinforces the intellectual property barrier around key Anteris technologies, in particular for its ComASUR transfemoral delivery system and maintains the sterile status of the product in the supply chain, from the point of manufacture to the operating room. .

The patent will help protect against potential infringement of the product and add to the commercial value of the product.

ComASUR is a commissural alignment device that can help surgeons position the heart valve as precisely as possible, which expands like a balloon when placed.

Source link

Previous Dubber's share price drops despite $ 110 million fundraising (ASX: DUB)
Next Poseidon Nickel Ltd announced pending fundraising

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *